This article is more than 5 years old. Information may no longer be current.

Synergy receives expanded FDA clearance for Biosphere Putty

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Synergy Biomedical announced recently that it has received 510(k) clearance from the U.S. Food and Drug Administration to expand the indications for its bone graft extender.

Synergy Biomedical’s Biosphere Putty is designed to be gently packed into bony voids or gaps of the skeletal system as a bone void filler in the extremities and pelvis.

The putty can now also be used in the posterolateral spine, providing a bone void filler that resorbs and is replaced with bone during the healing process, according to a company press release.

Biosphere Putty is Synergy Biomedical’s first bone graft product that uses bioactive glass spheres, which have been shown to improve the bone-healing properties of bioactive glass, according to the press release.